ArticlePlant cell reports2026
Salicylic acid-mediated biosynthesis of anti-oomycete diterpenoids in Euphorbia lathyris L. suspension cells.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
key messageSalicylic acid treatment significantly enhances the production of bioactive Euphorbia diterpenoids in Euphorbia lathyris suspension cultures by activating defense and diterpenoid biosynthetic pathways, including upregulating the key acyltransferase gene ElBAHD1. The medicinal plant Euphorbia lathyris produces pharmacologically active diterpenoids, but the content of which is limited in Euphorbia plants. An efficient suspension culture system of E. lathyris was established to enhance the production of bioactive diterpenoids. Salicylic acid (SA) treatment (550 μM, 10 days) significantly enhanced the production of lathyrane-type diterpenoids jolkinol A' (1), jolkinol A (2), jolkinol B (5), and a new 16-hydroxylated jolkinol A derivative (7). In particular, the volumetric yield of jolkinol A (2) was achieved to 47.00 mg L
Indexed as
Identifiers
41949771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.